Cotempla is an extended-release orally disintegrating tablet intended to treat ADHD in patients ages 6 to 17 years. The pill dissolves in a patient’s mouth with no need for water or chewing, according to a news release.
Neos plans to launch Cotempla as a portable blister pack this fall.
More articles on supply chain:
25 top supply chains in 2017, as ranked by Gartner
Baltimore’s naloxone supply dwindling as opioid overdose rates surge
Patients seeking financial assistance for $750k Biogen drug must sign away PHI
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
